Expediated Carboplatin for Treatment of Osteosarcoma in Dogs

Patient Disease:

Canine Osteosarcoma

Study Name:

Purpose of the study:

To determine if there is a survival benefit when adjuvant chemotherapy is started earlier, specifically the day after limb amputation surgery, in the treatment protocol for dogs having limb osteosarcoma
To evaluate how limb amputation wounds heal when IV carboplatin chemotherapy is administered
within 24 hours of surgery

Primary Eligibility Criteria:

Dogs with a bone tumor of the leg that will be undergoing full limb amputation
Owners intend to pursue carboplatin chemotherapy following amputation
No evidence of cancer spread
Pets must come to CSU for all visits related to the clinical trial

Study Protocol:

Dogs will undergo limb amputation and receive their first dose of carboplatin the day after surgery rather than 2 weeks after amputation (standard protocol)
Remainder of carboplatin protocol will be completed as per standard treatment

Owner Responsibilities:

To make and keep all appointments associated with treatment
Owners are responsible for all costs related to treatment of the pet’s disease including amputation
surgery and chemotherapy

Financial Incentives:

None

If you have further questions about any of our clinical trials, please submit an online consult form. Your consult will then be directed to our trials team. Requests are typically returned within 5 business days.